CA125 expression in patients with non-Hodgkin's lymphoma

被引：22

作者：

Gui, Wei ^{[1
]}

Zheng, Yuping ^{[1
]}

Wang, Jun ^{[1
]}

Yang, Bing ^{[1
]}

Zhang, Qiaohua ^{[1
]}

机构：

[1] Shanxi Tumor Hosp, Dept Hematol, Taiyuan, Shanxi, Peoples R China

来源：

LEUKEMIA & LYMPHOMA | 2006年 / 47卷 / 07期

关键词：

non-Hodgkin's lymphoma; CA125; serum level; tissue expression;

D O I：

10.1080/10428190600580882

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

The present study investigated the possible clinical significance of serum CA125 levels in patients with non-Hodgkin's lymphoma (NHL) and the mechanism of secretion. Serum CA125 levels in 335 patients with NHL were measured by enzyme-linked immunosorbent assay. The tissue CA125 expression in 22 patients with NHL was performed on paraffin section by immunohistochemical methods. One hundred and ninety-eight cases (59.1%) were found to have elevated serum CA125 levels. Serum CA125 levels were associated with clinical stage, effusions, high serum lactate dehydrogenase and beta(2)-M levels, and response to therapy. Microscopically, immunohistochemical staining revealed that malignant tumor cells demonstrated negative CA125 expression in all of the 22 cases. Our results suggested that serum CA125 levels could be an interesting tumor marker in NHL. The immunohistochemical study suggested that CA125 appeared not to be secreted by lymphoma cells directly.

引用

页码：1322 / 1326

页数：5

共 17 条

[1]

APEL RL, 1995, ARCH PATHOL LAB MED, V119, P373

[2]

Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma [J].

Bairey, O ;

Blickstein, D ;

Stark, P ;

Prokocimer, M ;

Nativ, HM ;

Kirgner, I ;

Shaklai, M .

LEUKEMIA & LYMPHOMA, 2003, 44 (10) :1733-1738

[3]

A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels [J].

Benboubker, L ;

Valat, C ;

Linassier, C ;

Cartron, G ;

Delain, M ;

Bout, M ;

Fetissof, F ;

Lefranq, T ;

Lamagnere, JP ;

Colombat, P .

ANNALS OF ONCOLOGY, 2000, 11 (11) :1485-1491

[4]

Burney IA, 1999, CANCER, V85, P755, DOI 10.1002/(SICI)1097-0142(19990201)85:3<755::AID-CNCR27>3.0.CO

[5]

2-O

[6]

CA 125 levels in patients with non-Hodgkin lymphoma and other hematologic malignancies [J].

Dilek, I ;

Ayakta, H ;

Demir, C ;

Meral, C ;

Ozturk, M .

CLINICAL AND LABORATORY HAEMATOLOGY, 2005, 27 (01) :51-55

[7]

A case of malignant lymphoma in a patient with high levels of CA125 and CA19-9 [J].

Kajiume, T ;

Yoshimi, S ;

Kobayashi, K ;

Kataoka, N .

PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2000, 17 (03) :269-272

[8]

High serum levels of CA125 and interleukin-6 in a patient with Ki-1 lymphoma [J].

Kubonishi, I ;

Bandobashi, K ;

Murata, N ;

Daibata, M ;

Ido, E ;

Sonobe, H ;

Ohtsuki, Y ;

Miyoshi, I .

BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (02) :450-452

[9]

Serum CA 125 levels in children with non-Hodgkin's lymphoma [J].

Kutluk, T ;

Varan, A ;

Erbas, B ;

Büyükpamukçu, M .

PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1999, 16 (04) :311-319

[10]

Lazzarino M, 1998, CANCER, V82, P576, DOI 10.1002/(SICI)1097-0142(19980201)82:3<576::AID-CNCR21>3.0.CO

← 1 2 →